Disease modifying agents of myeloproliferative neoplasms: A review

Medicine and Dentistry

• Disease 100%
• Myeloproliferative Neoplasm 100%
• Therapeutic Procedure 66%
• Patient 50%
• Comprehension 50%
• Symptom 33%
• Development 16%
• Age 16%
• Neoplasm 16%
• Comorbidity 16%
• Drug Therapy 16%
• Combination Therapy 16%
• Mortality 16%
• Leukemia 16%
• Pathogenesis 16%
• Chemotherapeutic Agent 16%
• Drug 16%
• Base 16%
• Targeted Therapy 16%
• Next Generation Sequencing 16%
• Hematopoiesis 16%
• Somatic Mutation 16%
• Disease Exacerbation 16%
• Clinical Study 16%
• Splenomegaly 16%